casemark/writing-equity-research-notes

Writing Equity Research Notes

When To Use

• Initiating coverage on a new equity name
• Updating an existing rating or price target after earnings, guidance changes, or material events
• Writing a thematic or sector note that includes individual stock views
• Preparing internal investment committee memos supporting buy/sell/hold recommendations
• Responding to client requests for a written opinion on a specific security

Inputs To Gather

• Company identifiers: Ticker, exchange, GICS sector/industry classification
• Financial statements: Last 3 years of income statement, balance sheet, and cash flow statement; most recent quarterly filing
• Consensus estimates: Street revenue, EPS, and EBITDA estimates for current and next two fiscal years
• Valuation data: Current share price, market cap, enterprise value, trading multiples (P/E, EV/EBITDA, EV/Revenue, FCF yield), and peer comparable set
• Catalyst calendar: Upcoming earnings date, product launches, regulatory decisions, index rebalance dates
• Management commentary: Latest earnings call transcript and investor day materials
• Prior coverage: Any existing internal notes, rating history, or price target changes on the name
• Compliance constraints: Firm-specific restricted list status, quiet period windows, and required disclosures [VERIFY]

Workflow

1. Define the note type and scope

   • Determine if this is an initiation, rating change, estimate revision, earnings recap, or thematic note
   • Confirm the target audience (institutional clients, internal portfolio managers, or investment committee)
   • Set the rating framework to use (e.g., Buy/Hold/Sell, Overweight/Equal-weight/Underweight) [VERIFY firm-specific rating scale]

2. Build the investment thesis

   • State the core thesis in 1-2 sentences: what the market is missing or mispricing
   • Identify 2-4 supporting pillars (revenue drivers, margin expansion levers, capital allocation, competitive moat)
   • Quantify each pillar where possible (e.g., "We see 300bps of gross margin expansion from mix shift into software")

3. Construct the financial model summary

   • Present key forecast assumptions: revenue growth, operating margin trajectory, capex intensity, and capital return
   • Show a condensed P&L bridge from consensus to your estimates, highlighting where and why you differ
   • Include a sensitivity table on the 1-2 variables that most move the valuation

4. Derive valuation and price target

   • Select primary valuation methodology (DCF, comparable multiples, sum-of-the-parts, or blend)
   • Justify the target multiple or discount rate with reference to historical trading range, peer set, and growth profile
   • Calculate the price target and implied upside/downside from current price
   • Present a bull/base/bear scenario framework with probability-weighted expected value if appropriate

5. Identify risks and mitigants

   • List the top 3-5 risks to the thesis, each with a brief mitigant or monitoring trigger
   • Distinguish between company-specific risks (execution, balance sheet, key-person) and macro/sector risks (regulatory, cyclical, FX)
   • Flag any binary event risks (FDA decision, litigation outcome, contract renewal) with expected timing

6. Draft the note

   • Open with a header block: ticker, rating, price target, current price, market cap, and key metrics
   • Lead with an executive summary (3-5 bullet points capturing rating, target, thesis, and key catalyst)
   • Organize body sections: Thesis, Financial Overview, Valuation, Risks, Appendix (model tables, comp tables)
   • Use concise, assertion-driven language; avoid hedging without substance

7. Add compliance disclosures

   • Include required ownership/conflict disclosures per firm policy and applicable regulation [VERIFY — FINRA 2241, MiFID II, or firm-specific requirements]
   • Add analyst certification language if required
   • Note any material non-public information restrictions or quiet period status

Output

The final research note should contain:

• Header block: Ticker | Rating | Price Target | Current Price | Market Cap | Sector
• Executive summary: 3-5 bullets with the actionable conclusion up front
• Investment thesis: Narrative with quantified supporting pillars
• Financial summary: Key estimates table, consensus comparison, sensitivity analysis
• Valuation: Methodology, target derivation, scenario analysis
• Risk factors: Prioritized list with mitigants
• Appendix: Detailed model, comparable company table, disclosures

Format as a professional research note with consistent heading hierarchy, right-aligned data tables, and source citations for third-party data.

Quality Checks

• [ ] Rating, price target, and implied return are internally consistent with the valuation methodology
• [ ] Estimates in the note match the financial model; no stale or contradictory figures
• [ ] Every quantitative claim has a sourced data point or is explicitly labeled as an estimate/assumption
• [ ] Bull/base/bear scenarios span a credible range and the base case aligns with the price target
• [ ] Risk factors are specific to this company and thesis — no generic boilerplate risks
• [ ] Compliance disclosures match the firm's current requirements [VERIFY]
• [ ] Tone is assertion-driven and professional; no unsupported superlatives ("best-in-class," "massive opportunity") without evidence
• [ ] Note is self-contained: a reader unfamiliar with the name can understand the thesis without external documents